[{"NetIncomeLoss_1_Q3_USD":-1550000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-633000.0,"OperatingLeaseLiability_0_Q3_USD":41700000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-55000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":42000.0,"MinorityInterestDecreaseFromRedemptions_3_Q3_USD":660000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q3_USD":-3839000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3_Q3_USD":-3989000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":50223000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":16177000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":132079000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":141100000.0,"InterestAndOtherIncome_3_Q3_USD":5910000.0,"InterestAndOtherIncome_1_Q3_USD":2430000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-55000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":42000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-197000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":6479000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1616000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":2468000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":14768646.0,"OtherNoncashIncomeExpense_3_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":700294000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":13000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":6567000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":59000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":142526000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-141169000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":1553000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":17897000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":435195000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":527000.0,"Liabilities_0_Q3_USD":442829000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":235551000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1100000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":128289000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":45287000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":53408000.0,"MinorityInterest_0_Q3_USD":-530000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-217000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1500000.0,"AccountsReceivableNetCurrent_0_Q3_USD":39487000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":237000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":237000.0,"CommonStockValue_0_Q3_USD":1412000.0,"GainLossOnTerminationOfLease_3_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":45761000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":1336000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3999000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":4186000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q3_USD":0.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1255823000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":38259000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":259393000.0,"OtherAssetsNoncurrent_0_Q3_USD":12683000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":3041000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":17873000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-76390000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-1271000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-80210000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":205039000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":146181000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":389434000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":1656000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":1698000.0,"Assets_0_Q3_USD":963710000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":71637000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":1344000.0,"VariableLeaseCost_3_Q3_USD":1600000.0,"VariableLeaseCost_1_Q3_USD":1000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-737377000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":178965000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2578000.0,"RestrictedCashNoncurrent_0_Q3_USD":1500000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":335002000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_3_Q3_USD":140000.0,"PaymentsToAcquireAdditionalInterestInSubsidiaries_3_Q3_USD":503000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":404000.0,"Goodwill_0_Q3_USD":40984000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":573000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":19066000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6682000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":3989000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":3839000.0,"NetIncomeLoss_3_Q3_USD":-80392000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":35282000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":899000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":6868000.0,"OperatingLeasePayments_3_Q3_USD":4700000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":1187000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":434850000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":520881000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":55569000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":11158000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":260893000.0,"LiabilitiesCurrent_0_Q3_USD":123561000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":6401000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":174170000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.062,"ShareBasedCompensation_3_Q3_USD":19066000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":10703000.0,"StockholdersEquity_0_Q3_USD":521411000.0,"ContractualObligation_0_Q3_USD":24313000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1187000.0,"InterestReceivableCurrent_0_Q3_USD":822000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":45761000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":11708000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":6705000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":9098000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":92392000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":57763000.0,"OperatingIncomeLoss_3_Q3_USD":-86120000.0,"OperatingIncomeLoss_1_Q3_USD":-3701000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":389434000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":87791000.0,"PreferredStockValue_0_Q3_USD":0.0,"OperatingLeaseCost_3_Q3_USD":7700000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":6238000.0,"ProfitLoss_1_Q3_USD":-1508000.0,"ProfitLoss_3_Q3_USD":-80447000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.01,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.61,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":267903000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"OperatingExpenses_3_Q3_USD":178512000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3441000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6682000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":19066000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":963710000.0,"OperatingLeaseCost_1_Q3_USD":4000000.0,"OperatingExpenses_1_Q3_USD":61464000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-76445000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]